David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 3,892 shares at $26.98 ($105K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Seasonal sale ($105k) by SVP, Life Sciences — this insider has traded PHR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.98 | 1,946 | $53K | 50.0% |
| 2 | $26.98 | 1,946 | $53K | 50.0% |
| Total | $26.98 avg | 3,892 | $105K | 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |